9789962906148
Disponible el:
DESCRIPCIÓN
The main reasonfor this advancement of the second editionof our book is the covid19 pandemic and the impact on cancer patients. With all the adverse effects they makethe delay in the diagnosis and treatmentof cancer patients. Thecovid19 pandemic transformedreality. Rarely have we hadcancer operations labeled as urgent, during this time it has become a norm, rather thanan exception: to deal withlockdowns, delays in detection and diagnosis, delays or interruptions in cancer treatments. Surgery, unless urgent due tobleeding, perforation or obstruction, was initially limitedto avoid patients or medical personnel contagion with the virus 21st century Pandemic. Lung cancer and those caused by infections will be those withthe greatest increase. Inthe rich area of the planet, prostate, colon and breast cancer willcontinue to have the highest incidence. Developing countries will suffer the evils of tobacco, which generates 12 percent of their cancer cases, a percentage that continues to grow.Another 25 percent of casesfind their origin in chronic diseases. Researchers estimate that by the year 2030, 1.7 million cancer cases will be diagnosed in Latin America and the Caribbean andmore than one million deaths from cancer. Panama,like many other Latin Americancountries was affected by The covid19 Pandemic.The impact will be seen on a short, medium and long range. In order to save ourpatients, we are implementing a Damage control strategy(DCS): first Stratification of our patients in Urgent, Priority and non-priorities.
The stratification can be withletters or numbers. During our General Surgery Residency Training a classificationof priorities that worked well wasCIDUR (Spanish Acronym for CIRUGIA DE URGENCIA) ( Dr.Enero Aviles personal communication).Multiple technologic changes, multiple virtual conferences and meetings were developed during the 2020 and the 2021. ThisBook has 57 chapters, the last tells the History of Oncology in Panama, linked to the History of Panama and the World.
Cesar Restrepo, MD Surgical OncologistFellow MD Anderson Hospitaland Tumor Institute, Houston Texas, USA. Corresponding Member of the Society of Surgical Oncology (SSO)
No hay reseñas de clientes en este momento.

680,50 €

19,80 €

9,95 €

9,95 €

9,95 €

72,20 € -5% 76,00 €

638,28 €

1 214,11 €

9,95 €

85,00 €

46,00 €

96,00 €

31,95 €

20,79 €

116,00 €

31,00 €

46,00 €

31,00 €

31,00 €

31,00 €

31,00 €

31,00 €

105,00 €

57,00 €

30,00 €

30,00 €

51,00 €

46,00 €

123,00 €

115,00 €
Conócenos
Estudiantes